01 May 2024 : Clinical Research
Comparison of Effects of Sugammadex and Neostigmine on Postoperative Neuromuscular Blockade Recovery in Patients with Interstitial Lung Diseases Undergoing Transbronchial Cryobiopsy: A Randomized Trial
Liya Lu1AB*, Xiaobo Chen2EF, Shiyue Li2F, Yanyi Cen1CDDOI: 10.12659/MSM.942773
Med Sci Monit 2024; 30:e942773
Table 1 Demographics and patients’ general characteristics.
| Parameters | Group C (n=32) | Group S (n=31) | P value |
|---|---|---|---|
| Sex (Female/Male) | 15/17 | 17/14 | 0.527 |
| Age | 48.0±13.6 | 46.3±13.8 | 0.635 |
| Body mass index | 22.6±3.0 | 22.0±2.7 | 0.415 |
| ASA I/II/III | 3/16/3 | 3/15/3 | 0.996 |
| FEV1 (% predicted) | 74.8±22.3 | 72.8±20.5 | 0.705 |
| FVC (% predicted) | 75.4±21.8 | 78.7±21.5 | 0.545 |
| FEV1/FVC (%) | 105.8 (24.7) | 97.0 (15.0) | 0.091 |
| DLCO (% predicted) | 61.5±19.8 | 59.9±20.1 | 0.755 |
| pH | 7.38±0.03 | 7.38±0.03 | 0.557 |
| PaO | 89.8 (35.0) | 95.0 (41.0) | 0.874 |
| PaCO | 42.0 (7.6) | 40.7 (8.0) | 0.695 |
| SaO | 97.1 (2.7) | 97.0 (2.0) | 0.663 |
| Data are presented as mean±standard deviation or count (n). ASA – American Society of Anesthesiologists physical status classifification; FEV – forced expiratory volume in first second; FVC – forced vital capacity; DLCO – carbon monoxide diffusing capacity. | |||